This page shows the latest bipolar disorder news and features for those working in and with pharma, biotech and healthcare.
Alkermes’ experimental antipsychotic for schizophrenia and bipolar I disorder ALKS 3831 has cleared an US Food and Drug Administration (FDA) expert advisory committee review. ... and bipolar I disorder,” said Craig Hopkinson, chief medical officer
Depakine has been marketed by Sanofi since 1967 as an anti-epileptic and bipolar disorder treatment, and has since been associated with foetus malformation and neurodevelopmental disorders including autism and spina
The dopamine D2, D3 receptor partial agonist for schizophrenia and bipolar disorder could top the $1bn blockbuster threshold, well ahead of analyst forecast of around half that amount at peak just ... A new approval in bipolar depression has contributed
Despite its maturity, the drug has been one of Sanofi’s reliable mid-size products, bringing in around 450m in sales from use in epilepsy and bipolar disorder in 2018.
Review begins for potential schizophrenia and bipolar I disorder drug. The FDA has started its review of Alkermes’ experimental antipsychotic for schizophrenia and bipolar I disorder – ALKS 3831 – setting up a ... Olanzapine is an effective and well
Second divestment to Germany-based Cheplapharm this year. AstraZeneca has sold the commercial rights to schizophrenia and bipolar disorder drugs Seroquel and Seroquel XR to Cheplapharm. .
More from news
Approximately 7 fully matching, plus 87 partially matching documents found.
As such, patients with coronary syndromes, multiple sclerosis, bipolar disorder and Hepatitis C were being denied access to effective treatments, while treatments for other diseases were also subject to restrictions.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
there’s an abundance of smart thinking on how to improve the lives of people who struggle with major depression, schizophrenia, bipolar disorder, and other serious conditions.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....